In vivo CD30 expression in human diseases with predominant activation of Th2-like T cells

Journal of Leukocyte Biology

Volumn 61, Issue 5, 1997, Pages 539-544

  D'Elios, M M ^a   Romagnani, P ^a   Scaletti, C ^a   Annunziato, F ^a   Manghetti, M ^b   Mavilia, C ^a   Parronchi, P ^a   Pupilli, C ^a   Pizzolo, G ^c   Maggi, E ^a   Del Prete, G F ^a   Romagnani, S ^a,d  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

^d Ist Med Int e Immunoallergologia   (Italy)

Author keywords

chronic graft versus host disease; Crohn's disease; gastric antritis; Helicobacter pylori; multiple sclerosis; systemic sclerosis

Indexed keywords

CD30 ANTIGEN; GAMMA INTERFERON;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; GASTRITIS; GRAFT VERSUS HOST REACTION; HELICOBACTER PYLORI; HELPER CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS;

EID: 0031007377     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.61.5.539     Document Type: Article

References (31)

1. Smith, C. A., Gruss, H-J., Davis, T., Anderson, D., Farrah, T., Baker, E., Sutherland, G. R., Brannan, C. I., Copeland, N. G., Jenkins, N. A., Grabstein, K. H., Gliniak, B., McAllister, I. B., Fanslow, W., Alderson, M., Falk, B., Gimpel, S., Gillis, S., Din, W. S., Goodwin, R. G., Armitagen, R. J. (1993) CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 73, 1349-1360.
2. Stein, H., Mason, D. Y., Gerdes, J., O'Connor, N., Wainscoat, J., Pallesen, G., Gatter, K., Falini, B., Delson, G., Lemke, H., Schwarting, R., Lennert, K. (1985) The expression of Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that the Reed Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66, 848-858.
3. + T cell clones in human immunodeficiency virus infection. J. Exp. Med. 180, 2407-2411.
4. + T cells producing Th2-type cytokines. FASEB J. 9, 81-86.
5. Del Prete, G. F., De Carli, M., D'Elios, M. M., Daniel, K. C., Smith, C. A., Thomas, E., Romagnani, S. (1995) CD30-mediated signalling promotes the development of human Th2-like T cells. J. Exp. Med. 182, 1-7.
6. McDonald, P. P., Cassatella, M. A., Bald, A., Maggi, E., Romagnani, S., Gruss, H-J., Pizzolo, G. (1995) CD30 ligation induces nuclear factor-κB activation in human T cell lines. Eur. J. Immunol. 25, 2870-2876.
7. Chilosi, M., Facchetti, F., Notarangelo, L. D., Romagnani, S., Del Prete, G-F., Almerigogna, F., De Carli, M., Pizzolo, G. (1996) CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn's syndrome. Evidence for a Th2-mediated condition. Eur. J. Immunol. 26, 329-334.
8. Schandené, L., Ferster, A., Mascart-Lemone, F., Crusiaux, A., Gérard, C., Marchant, A., Lybin, M., Vélu, T., Goldman, M. (1993) T helper type 2-like cells and therapeutic effects of interferon-γ in combined immunodeficiency with hypereosinophilia (Omenn's syndrome). Eur. J. Immunol. 23, 56-60.
9. Pupilli, C., Ariel Gomez, R., Tuttle, J. B., Peach, M. J., Carey, M. R. (1991) Spatial association of renin-containing cells and nerve fibers in developing rat kidney. Ped. Nephrol. 5, 690-695.
10. D'Elios, M. M., Minghetti, M., De Carli, M., Costa, F., Baldari, C. T., Burroni, D., Telford, J. L., Romagnani, S., Del Prete, G. F. (1997) Th1 effector cells specific for Helicobacter pilori in the gastric antrum of patients with peptic ulcer disease. J. Immunol., in press.
11. Pizzolo, G., Vinante, F., Morosato, L., Nadali, G., Chilosi, M., Gandini, G., Sinicco, A., Raiteri, S., Semenzato, G., Stein, H., Perona, G. (1994) High serum level of soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS. AIDS 8, 741-745.
12. Mohammadi, M., Czinn, S., Redline, R., Nedrud, J. (1996) Helicobacter-specific cell-mediated immune responses display a predominant Th1 phenotype and promote a delayed-type hypersensitivity response in the stomachs of mice. J. Immunol. 156, 4729-4738.
13. Mullin, G. E., Maycon, Z. R., Sampat, A., Vezza, F. R., Braun-Elwert, L., Duchmann, R., Weissman, G., Katz, S., McKinley, M., James, S. P., Fisher, S. E. (1993) Intestinal mucosal lymphokine production in Crohn's disease has a Th1 profile. Gastroenterology 104, A750.
14. + lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. J. Immunol. 157, 1261-1270.
15. Parronchi, P., Romagnani, P., Annunziato, F., Sampognaro, S., Becchio, A., Giannarini, A., Maggi, E., Pupilli, C., Tonelli, F., Romagnani, S. (1997) Type 1 T helper (Th1)-cell predominance and IL-12 expression in the gut of patients with Crohn's disease. Am. J. Pathol., in press.
16. Selmaj, K., Raine, C. S., Cannella, B., Brosnan, C. F. (1991) Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J. Clin. Invest. 87, 949-954.
17. Windhagen, A., Newcombe, J., Dangond, F., Strand, C., Woodroofe, M. N., Cuzner, M. L., Hafler, D. A. (1995) Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin-12 cytokine in multiple sclerosis lesions. J. Exp. Med. 182, 1985-1996.
18. White Needelman, B., Wigley, F. M., Stair, R. W. (1992) IL-1, IL-2, IL-4, IL-6, TNF-alpha, IFN-gamma levels in sera from patients with scleroderma. Arthr. Rheumatol. 35, 67-72.
19. De Wit, D., Van Mechelen, M., Zanin, C., Dautrelepont, J-M., Velu, T., Gérard, T., Abramowicz, D., Scheerlink, J. P., De Baetselier, P., Urbain, J., Leo, O., Goldman, M., Moser, M. (1993) Preferential activation of Th2 cells in chronic graft-versus-host reaction. J. Immunol. 150, 361-363.
20. Alzona, M., Jack, H-M., Fisher, R. I., Ellis, T. M. (1994) CD30 defines a subset of activated human T cells that produce IFN-γ and IL-5 and exhibit enhanced B cell helper activity. J. Immunol. 153, 2861-2867.
21. Manetti, R., Parronchi, P., Giudizi, M-G., Piccinni, M-P., Maggi, E., Trinchieri, G., Romagnani, S. (1993) Natural killer cell stimulatory factor (interleukin-12) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177, 1199-1204.
22. + T cells. J. Immunol. 154, 9-16.
23. Bengtsson, A., Johansson, C., Linder, M. T., Haliden, G., Van Der Ploeg, I., Scheynius, A. (1995) Not only Th2 cells but also Th1 and Th0 cells express CD30 after activation. J. Leukoc. Biol. 58, 683-689.
24. Hamman, D., Hilkens, C. M. U., Grogan, J. L., Lens, S. M. A., Kapsenberg, M. L., Yazdanbakhash, M., Van Lier, R. A. W. (1996) CD30 expression does not discriminate between human Th1-and Th2-type T cells. J. Immunol. 156, 1387-1391.
25. Seitzer, U., Flad, H. D., Gerdes, J. (1996) Within the spectral forms of leprosy cellbound CD30 cannot be regarded as an operational marker for the Th2-like reaction. J. Leukoc. Biol. 59, 311.
26. Maggi, E., Biswas, P., Del Prete, G. F., Parronchi, P., Macchia, D., Simonelli, C., Emmi, L., De Carli, M., Tiri, A., Ricci, M., Romagnani, S. (1991) Accumulation of Th2-like helper T cells in the conjunctiva of patients with vernal conjunctivitis. J. Immunol. 15, 1169-1174.
27. Kay, A. B., Ying, S., Varney, V., Gaga, M., Durham, S. R., Moqbel, R., Wardlaw, A. J., Hamid, Q. (1991) Messenger RNA expression of the cytokine gene cluster, interleukin-3 (IL-3, IL-4, IL-5 and granulocyte/macrophage colony stimulating factor), in allergen-induced late phase cutaneous reactions in atopic subjects. J. Exp. Med. 173, 775-778.
28. Romagnani, S. (1994) Regulation of Th2 development in allergy. Curr. Op. Immunol. 6, 838-846.
29. Bradding, P., Feather, I. H., Howarth, P. H., Mueller, R., Roberts, J. A., Britten, K., Bews, J. P., Hunt, T. C., Okayama, Y., Heusser, C. H., Bullock, R. H., Church, M. K., Holgate, S. T. (1992) Interleukin 4 is localized and released by human mast cells. J. Exp. Med. 176, 1381-1386.
30. Mueller, R., Heusser, C. H., Rihs, S., Brunner, T., Bullock, G. R., Dahinden, C. A. (1994) Immunolocalization of intracellular interleukin-4 in normal human peripheral blood basophils. Eur. J. Immunol. 24, 2935-2940.
31. + T cells by IL-4 and IFN-γ. J. Immunol., in press.